Co-Diagnostics, Inc. (CODX) financial statements and ratios from SEC XBRL: revenue $622489.00 (TTM), net margin -7533.6%, revenue growth -84.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $622489.00 |
| Net Margin | -7533.6% |
| Revenue Growth (YoY) | -84.1% |
| EPS Growth (YoY) | 2742.7% |
| FCF Growth (YoY) | -0.2% |
| Price / Book | 0.57 |
| Price / Sales | 12.02 |
| FCF Yield | -753.4% |
| Altman Z-Score | -10.11 (distress) |
| Sector P/E (Healthcare) | 21.6 |
CODX overview · CODX earnings · CODX KPIs · CODX investor relations · CODX ownership · CODX peers · CODX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.